The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin

Converging lines of evidence from varied scientific disciplines suggest that cutaneous melanomas comprise biologically distinct subtypes that arise through multiple causal pathways. Understanding the respective relationships of each subtype with etiologic factors such as UV radiation and constitutional factors is the first necessary step toward developing refined prevention strategies for the specific forms of melanoma. Furthermore, classifying this disease precisely into biologically distinct subtypes is the key to developing mechanism‐based treatments, as highlighted by recent discoveries. In this review, we outline the historical developments that underpin our understanding of melanoma heterogeneity, and we do this from the perspectives of clinical presentation, histopathology, epidemiology, molecular genetics, and developmental biology. We integrate the evidence from these separate trajectories to catalog the emerging major categories of melanomas and conclude with important unanswered questions relating to the development of melanoma and its cells of origin.

[1]  D. Whiteman,et al.  Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection. , 2011, Journal of the American Academy of Dermatology.

[2]  J. Choi,et al.  Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta‐analysis , 2011, The British journal of dermatology.

[3]  A. Hara,et al.  Functionally distinct melanocyte populations revealed by reconstitution of hair follicles in mice , 2011, Pigment cell & melanoma research.

[4]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[5]  A. Bowcock,et al.  Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas , 2010, Science.

[6]  D. Schadendorf,et al.  Genetic and morphologic features for melanoma classification , 2010, Pigment cell & melanoma research.

[7]  A. Hauschild,et al.  Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors. , 2010, The Journal of investigative dermatology.

[8]  J. O'Brien,et al.  Mutations in GNA11 in uveal melanoma. , 2010, The New England journal of medicine.

[9]  D. Whiteman,et al.  Estimating the attributable fraction for melanoma: A meta‐analysis of pigmentary characteristics and freckling , 2010, International journal of cancer.

[10]  V. Hearing,et al.  The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin , 2010, Journal of Cell Science.

[11]  J. Barrett,et al.  Melanocytic Nevi, Nevus Genes, and Melanoma Risk in a Large Case-Control Study in the United Kingdom , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[12]  I. Adameyko,et al.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes , 2010, Cellular and Molecular Life Sciences.

[13]  M. Ziman,et al.  PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas) , 2010, PloS one.

[14]  M. Herlyn,et al.  Human dermal stem cells differentiate into functional epidermal melanocytes , 2010, Journal of Cell Science.

[15]  N. Dhomen,et al.  Inducible expression of V600EBraf using tyrosinase‐driven Cre recombinase results in embryonic lethality , 2010, Pigment cell & melanoma research.

[16]  D. Whiteman,et al.  Familial Melanoma: A Meta-analysis and Estimates of Attributable Fraction , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[17]  W. Pavan,et al.  NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation , 2009, Pigment cell & melanoma research.

[18]  G. Reifenberger,et al.  Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system , 2009, Acta Neuropathologica.

[19]  U. Suter,et al.  Schwann Cell Precursors from Nerve Innervation Are a Cellular Origin of Melanocytes in Skin , 2009, Cell.

[20]  Y. Korchev,et al.  Functional neurons and melanocytes induced from immortal lines of postnatal neural crest-like stem cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  C. Garbe,et al.  Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma , 2009, British Journal of Cancer.

[22]  A. Hara,et al.  Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of non-cutaneous and dermal versus epidermal melanocytes , 2009, Development.

[23]  J. Malvehy,et al.  Genome-wide association study identifies three loci associated with melanoma risk , 2009, Nature Genetics.

[24]  T. Spector,et al.  Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi , 2009, Nature Genetics.

[25]  S. Cramer Stem Cells for Epidermal Melanocytes-A Challenge for Students of Dermatopathology , 2009, The American Journal of dermatopathology.

[26]  R. DePinho,et al.  BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.

[27]  T. Mack,et al.  Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis , 2009, International journal of cancer.

[28]  T. Gojobori,et al.  Specific expression of Gsta4 in mouse cochlear melanocytes: a novel role for hearing and melanocyte differentiation , 2009, Pigment cell & melanoma research.

[29]  N. Yoo,et al.  Somatic mutation of GNAQ gene is rare in common solid cancers and leukemias , 2009, Acta oncologica.

[30]  E. Simpson,et al.  Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi , 2008, Nature.

[31]  M Laurin Council,et al.  Oncogenic mutations in GNAQ occur early in uveal melanoma. , 2008, Investigative ophthalmology & visual science.

[32]  Susan Muller,et al.  KIT Gene Mutations and Copy Number in Melanoma Subtypes , 2008, Clinical Cancer Research.

[33]  D. Elder,et al.  MC1R variants increase risk of melanomas harboring BRAF mutations. , 2008, The Journal of investigative dermatology.

[34]  D. Pinkel,et al.  Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. , 2008, The Journal of investigative dermatology.

[35]  Christopher Y. Park,et al.  Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects , 2008, Nature Genetics.

[36]  Kari Stefansson,et al.  ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.

[37]  Jane Fridlyand,et al.  Improving Melanoma Classification by Integrating Genetic and Morphologic Features , 2008, PLoS medicine.

[38]  C. Tohyama,et al.  Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/ β‐catenin signaling in keratinocytes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  Snæbjörn Pálsson,et al.  Genetic determinants of hair, eye and skin pigmentation in Europeans , 2007, Nature Genetics.

[40]  R. Millikan,et al.  Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[41]  V. Hearing,et al.  The effects of dickkopf 1 on gene expression and Wnt signaling by melanocytes: mechanisms underlying its suppression of melanocyte function and proliferation. , 2007, The Journal of investigative dermatology.

[42]  V. Siskind,et al.  A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001 , 2007, Cancer Causes & Control.

[43]  M. Trivett,et al.  Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. , 2007, The Journal of investigative dermatology.

[44]  L. Larue,et al.  Notch1 and Notch2 receptors influence progressive hair graying in a dose‐dependent manner , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[45]  J. Lundeberg,et al.  NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing , 2006, Melanoma research.

[46]  D. Pinkel,et al.  Somatic activation of KIT in distinct subtypes of melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  D. Pinkel,et al.  MC1R germline variants confer risk for BRAF-mutant melanoma. , 2006, Science.

[48]  Stephen B Gruber,et al.  BRAF and NRAS mutations in melanoma and melanocytic nevi , 2006, Melanoma research.

[49]  G. Saldanha,et al.  Cutaneous Melanoma Subtypes Show Different BRAF and NRAS Mutation Frequencies , 2006, Clinical Cancer Research.

[50]  Howard Y. Chang,et al.  Anatomic Demarcation by Positional Variation in Fibroblast Gene Expression Programs , 2006, PLoS genetics.

[51]  D. Krahl,et al.  The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites. , 2006, International journal of oncology.

[52]  D. Whiteman,et al.  Anatomic site, sun exposure, and risk of cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  L. Chin,et al.  Amplification of CDK4 and MDM2 in malignant melanoma , 2006, Genes, chromosomes & cancer.

[54]  V. Alexeev,et al.  Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. , 2006, The Journal of investigative dermatology.

[55]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[56]  R. MacKie,et al.  Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. , 2005, The Journal of investigative dermatology.

[57]  R. Gallagher,et al.  Etiologic and Other Factors Predicting Nevus-Associated Cutaneous Malignant Melanoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[58]  T. Kunisada,et al.  Cooperative and indispensable roles of endothelin 3 and KIT signalings in melanocyte development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[59]  J. Davison,et al.  Absence of V599E BRAF mutations in desmoplastic melanomas , 2005, Cancer.

[60]  K. Richards,et al.  Neural crest cell lineage segregation in the mouse neural tube , 2004, Development.

[61]  S. Creuzet,et al.  Neural crest cell plasticity and its limits , 2004, Development.

[62]  Helmut Fuchs,et al.  Effects of G-protein mutations on skin color , 2004, Nature Genetics.

[63]  Kazuhiro Takahashi,et al.  BRAF point mutations in primary melanoma show different prevalences by subtype. , 2004, The Journal of investigative dermatology.

[64]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[65]  Daniel Pinkel,et al.  Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.

[66]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[67]  E. Dupin,et al.  Development of melanocyte precursors from the vertebrate neural crest , 2003, Oncogene.

[68]  P. Meltzer,et al.  Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia , 2003, Nature Genetics.

[69]  W. Goggins,et al.  The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. , 2003, Archives of dermatology.

[70]  D. Ruiter,et al.  Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization , 2003, Genes, chromosomes & cancer.

[71]  K. R. Fitch,et al.  Genetics of dark skin in mice. , 2003, Genes & development.

[72]  L. Kanter,et al.  Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[73]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[74]  D. Pinkel,et al.  Cyclin D1 is a candidate oncogene in cutaneous melanoma. , 2002, Cancer research.

[75]  S. Nishikawa,et al.  Dominant role of the niche in melanocyte stem-cell fate determination , 2002, Nature.

[76]  R. Westendorp,et al.  The melanocortin-1-receptor gene is the major freckle gene. , 2001, Human molecular genetics.

[77]  J. J. van den Oord,et al.  A novel N-ras mutation in malignant melanoma is associated with excellent prognosis. , 2001, Cancer research.

[78]  R. MacKie,et al.  Development of melanocytic nevi in the first three years of life. , 2000, Journal of the National Cancer Institute.

[79]  M. Pasdar,et al.  Plasticity of cadherin-catenin expression in the melanocyte lineage. , 2000, Pigment cell research.

[80]  M. Catala,et al.  The developmental potentials of the caudalmost part of the neural crest are restricted to melanocytes and glia , 2000, Mechanisms of Development.

[81]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[82]  T. Godfrey,et al.  Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. , 2000, Cancer research.

[83]  J. Bulliard Site‐specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand , 2000, International journal of cancer.

[84]  S. Nishikawa,et al.  Regulation of E- and P-cadherin expression correlated with melanocyte migration and diversification. , 1999, Developmental biology.

[85]  D. Whiteman,et al.  Determinants of melanocyte density in adult human skin , 1999, Archives of Dermatological Research.

[86]  J F Aitken,et al.  A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.

[87]  A Biggeri,et al.  Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. , 1999, Journal of the American Academy of Dermatology.

[88]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[89]  V. Bataille,et al.  Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.

[90]  D. Whiteman,et al.  p53 expression and risk factors for cutaneous melanoma: A case‐control study , 1998, International journal of cancer.

[91]  S. Nishikawa,et al.  Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. , 1998, Development.

[92]  BL Diffey,et al.  The confounding influence of sun exposure in melanoma , 1998, The Lancet.

[93]  J. Bulliard,et al.  Comparison of the site distribution of melanoma in New Zealand and Canada , 1997, International journal of cancer.

[94]  W. Pavan,et al.  Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. , 1997, Development.

[95]  T. Holford,et al.  Malignant melanoma risk factors by anatomic site: A case‐control study and polychotomous logistic regression analysis , 1996, International journal of cancer.

[96]  N. Hayward,et al.  Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. , 1996, The American journal of pathology.

[97]  C. la Vecchia,et al.  Site distribution of different types of skin cancer: New aetiological clues , 1996, International journal of cancer.

[98]  D. English,et al.  Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? , 1995, Journal of the American Academy of Dermatology.

[99]  D. Easton,et al.  Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .

[100]  Renato Panizzon,et al.  Overall and site‐specific risk of malignant melanoma associated with nevus counts at different body sites: A multicenter case‐control study of the german central malignant‐melanoma registry , 1995, International journal of cancer.

[101]  H. Höfler,et al.  Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma. , 1995, The Journal of investigative dermatology.

[102]  J. Bulliard,et al.  Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand , 1994, Cancer Causes & Control.

[103]  V. Siskind,et al.  Naevi in schoolchildren in Scotland and Australia , 1994, The British journal of dermatology.

[104]  J. Hoeffler,et al.  Ras mutations in human melanoma: a marker of malignant progression. , 1994, The Journal of investigative dermatology.

[105]  D. English,et al.  Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. , 1994, American journal of epidemiology.

[106]  N. Martin,et al.  Site distribution of cutaneous melanoma in queensland , 1993, International journal of cancer.

[107]  A. Green,et al.  A theory of site distribution of melanomas: Queensland, Australia , 1992, Cancer Causes & Control.

[108]  C. Garbe,et al.  Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. , 1992, Journal of the American Academy of Dermatology.

[109]  J. Nordlund,et al.  Neural-tube-derived melanocyte subsets undergo commitment to their distinct lineages in culture. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[110]  J. Liff,et al.  Plantar melanoma: Is the incidence of melanoma of the sole of the foot really higher in blacks than whites? , 1990, International journal of cancer.

[111]  L. J. Veer,et al.  N-ras mutations in human cutaneous melanoma from sun-exposed body sites , 1989, Molecular and cellular biology.

[112]  W. Willett,et al.  Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. , 1989, Journal of the National Cancer Institute.

[113]  E. Holly,et al.  Number of melanocytic nevi as a major risk factor for malignant melanoma. , 1987, Journal of the American Academy of Dermatology.

[114]  A. Ackerman,et al.  A unifying concept of malignant melanoma: biologic aspects. , 1986, Human pathology.

[115]  D. Vågerö,et al.  Melanoma and other tumors of the skin among office, other indoor and outdoor workers in Sweden 1961-1979. , 1986, British Journal of Cancer.

[116]  V. Siskind,et al.  Common acquired naevi and the risk of malignant melanoma , 1985, International journal of cancer.

[117]  B. Armstrong,et al.  Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. , 1984, Journal of the National Cancer Institute.

[118]  L. Old,et al.  Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? , 1984, Nature.

[119]  B K Armstrong,et al.  Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. , 1984, Journal of the National Cancer Institute.

[120]  A. Ackerman Malignant melanoma: a unifying concept. , 1980, Human pathology.

[121]  D. Strickland,et al.  Malignant melanoma: social status and outdoor work. , 1980, British Journal of Cancer.

[122]  A. Swerdlow Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine. , 1979, British medical journal.

[123]  I. Crombie Variation of melanoma incidence with latitude in North America and Europe. , 1979, British Journal of Cancer.

[124]  M. Hinds,et al.  Anatomic distribution of malignant melanoma of the skin among non-Caucasians in Hawaii. , 1979, British Journal of Cancer.

[125]  I. Crombie Racial differences in melanoma incidence. , 1979, British Journal of Cancer.

[126]  B. Gilchrest,et al.  Effects of aging and chronic sun exposure on melanocytes in human skin. , 1979, The Journal of investigative dermatology.

[127]  T. Hakulinen,et al.  Sunlight as a risk factor of malignant melanoma of the skin , 1978, Cancer.

[128]  I. Fleming,et al.  Skin cancer in black patients , 1975, Cancer.

[129]  W. Clark,et al.  The classification of malignant melanoma and its histologic reporting , 1973, Cancer.

[130]  K. Magnus Incidence of malignant melanoma of the skin in Norway, 1955–1970. Variations in time and space and solar radiation , 1973, Cancer.

[131]  Morag Bell,et al.  A STUDY ON THE EFFECTS OF IBUPROFEN ON THE METABOLISM OF ANTIPYRINE IN MAN , 1973, The Medical journal of Australia.

[132]  J. A. Lee,et al.  SUNLIGHT AND THE AETIOLOGY OF MALIGNANT MELANOMA: A SYNTHESIS , 1970, The Medical journal of Australia.

[133]  W. C. Quevedo,et al.  Influence of age and UV on the populations of dopa-positive melanocytes in human skin. , 1969, The Journal of investigative dermatology.

[134]  M. G. Lewis,et al.  Malignant melanoma in Uganda. , 1968, East African medical journal.

[135]  G. Szabó The regional anatomy of the human integument with special reference to the distribution of hair follicles, sweat glands and melanocytes , 1967, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.

[136]  M. G. Lewis Malignant melanoma in Uganda. (The relationship between pigmentation and malignant melanoma on the soles of the feet). , 1967, British Journal of Cancer.

[137]  Forbes Ja Infectious diseases, today and tomorrow. , 1966 .

[138]  W. C. Quevedo,et al.  Melanocyte populations in UV-irradiated human skin. , 1965, The Journal of investigative dermatology.

[139]  R. Winkelmann,et al.  PIGMENT ACTIVITY IN DERMAL NEVI INDUCED BY ULTRAVIOLET LIGHT: AN ENZYME HISTOCHEMICAL STUDY. , 1965, The Journal of investigative dermatology.

[140]  R. Mitchell THE EFFECT OF PROLONGED SOLAR RADIATION ON MELANOCYTES OF THE HUMAN EPIDERMIS. , 1963, The Journal of investigative dermatology.

[141]  R. Billingham Announcement:Third Annual Herman Beerman Lecture: Transplantation: Past, Present and Future , 1963 .

[142]  Lancaster Ho,et al.  Some geographical aspects of the mortality from melanoma in Europeans. , 1956 .

[143]  G. Szabó,et al.  The Number of Melanocytes in Human Epidermis , 1954, British medical journal.

[144]  V. McGovern MELANOBLASTOMA , 1952, The Medical journal of Australia.

[145]  M E RAWLES,et al.  Origin of Pigment Cells from the Neural Crest in the Mouse Embryo , 1947, Physiological Zoology.

[146]  N. Bhatia Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis , 2012 .

[147]  M. Berwick,et al.  Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. , 2008, The Journal of investigative dermatology.

[148]  A. Glick,et al.  Endothelin 3 induces skin pigmentation in a keratin-driven inducible mouse model. , 2008, The Journal of investigative dermatology.

[149]  C. Warneke,et al.  Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. , 2006, The Journal of investigative dermatology.

[150]  P. Leboit,et al.  Pathology and genetics of skin tumours , 2006 .

[151]  J. Barrett,et al.  The effect of sun exposure in determining nevus density in UK adolescent twins. , 2005, The Journal of investigative dermatology.

[152]  S. Fraitag [Melanocytic nevi in children]. , 2004, Annales de pathologie.

[153]  P. Meltzer,et al.  High frequency of BRAF mutations in nevi , 2003, Nature Genetics.

[154]  J. Downward Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[155]  D. Duffy,et al.  Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? , 2000, American journal of human genetics.

[156]  S. Harrison,et al.  Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. , 1994, Journal of the American Academy of Dermatology.

[157]  C. Cordon-Cardo,et al.  Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. , 1989, Oncogene.

[158]  H. Pinkus,et al.  Quantitative and qualitative data on the pigment cells of adult human epidermis. , 1957, The Journal of investigative dermatology.

[159]  H. Pinkus,et al.  Quantitative and Qualitative Data on the Pigment Cells of Adult Human Epidermis1 , 1957 .

[160]  H. O. Lancaster Some geographical aspects of the mortality from melanoma in Europeans. , 1956, The Medical journal of Australia.